Search Results

You are looking at 41 - 50 of 74 items for :

  • "Beta blockers" x
  • Refine by Access: All Content x
Clear All

mortality risk led to its removal from clinical use [ 61 ]. Beta-blockers are an existing therapy used to reduce blood pressure, which have properties that may make them effective neuroprotectants. They have established efficacy for hemodynamic

Open access
Interventional Medicine and Applied Science
Authors: Ziya Totonchi, Shirin Salajegheh, Mahmoud Reza Mohaghegh, Mehrdad’Mesbah Kiaei, Mohammad Shirvani, and Masoud Ghorbanlo

use, and cardiovascular medications such as beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors and diuretics ( P  > 0.05) (Table   I ) . Table I Patients demographic and

Open access

. Ophthalmol. 43 S214 222 Altan-Yaycioglu R, Türker G, Acunas G, Izgi B: The effects of beta-blockers on ocular

Restricted access

Ubbink, D. T., Verhaar, E. E., Lie, H. K. és mtsa: Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J. Vasc. Surg., 2003, 38 , 535–540. Lie H. K

Restricted access
Orvosi Hetilap
Authors: Anita Pálinkás, Nóra Kovács, Valéria Sipos, Ferenc Vincze, Magor Papp, Árpád Czifra, Róza Ádány, and János Sándor

Healthcare Effectiveness Data and Information Set (HEDIS). The State of Health Care Quality – Persistence of Beta-Blocker Treatment After a Heart Attack. Available from: http

Open access
Orvosi Hetilap
Authors: Edit Szomják, Henrietta Dér, György Kerekes, Katalin Veres, Judit Tóth, Sándor Olvasztó, Csaba Herczku, and Pál Soltész

1789 1794 Kertai, M. D., Boersma, E., Bax, J. J. és mtsai: Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy

Restricted access

Psaty, B. M., Koepsell, T. D., Wagner, E. H., et al.: The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA, 1990, 263 , 1653–1657. Wagner E. H

Restricted access
Orvosi Hetilap
Authors: Eszter Kirilly, Xénia Gonda, Gabriella Juhász, and György Bagdy

Thiessen, B. Q., Wallace, S. M., Blackburn, J. L., et al.: Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch. Intern. Med., 1990, 150 , 2286–2290. Blackburn J. L

Open access
Orvosi Hetilap
Authors: József Borbola, Csaba Földesi, Attila Kardos, and Zoltán Som

-blind, crossover evaluation. J Am Coll Cardiol. 2012; 60: 1323–1329. 28 Qiu S, Shi S, Ping H, et al. Efficacy of ivabradine versus beta-blockers for heart

Restricted access
Orvosi Hetilap
Authors: István Lőrincz, Zoltán Szabó, József Simkó, Eszter Szánthó, Kitti Barta, Márta Füzi, and Gyula Szigeti

Pacing Clin. Electrophysiol. 2004 27 33 37 Ramaswamy, K.: Beta blockers improve

Restricted access